Oncology Clinical Trials
Find clinical trials for oncology. Search for oncology clinical trials in different cities and states across the United States.
Olvimulogene Nanivacirepvec & Platinum-doubletEfficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Sponsor:
Genelux Corporation
Location:
Code:
NCT06463665
Conditions
Advanced Non-squamous Non-small-cell Lung Cancer
Advanced Squamous Non-Small Cell Lung Carcinoma
Metastatic Non-squamous Non Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Carcinoma
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Olvimulogene nanivacirepvec
Platinum chemotherapy: carboplatin or cisplatin
Non-platinum chemotherapy: paclitaxel or nab-paclitaxel for squamous cell NSCLC or pemetrexed for nonsquamous cell NSCLC
Physician's Choice of Immune Checkpoint Inhibitor: pembrolizumab, nivolumab, cemiplimab, atezolizumab, durvalumab
Docetaxel
LV20.19 & PirtobrutinibLV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Sponsor:
Medical College of Wisconsin
Location:
Code:
NCT05990465
Conditions
Non Hodgkin Lymphoma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Pirtobrutinib
LV20.19 CAR T cells
N-AcetylcysteineAn Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms
Sponsor:
UCLA
Location:
Code:
NCT05123365
Conditions
Myeloproliferative Neoplasm
MPN
Essential Thrombocythemia
Polycythemia Vera
Myelofibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
N-Acetylcysteine
mEPICTechnical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Sponsor:
Ciusss de L'Est de l'Île de Montréal
Location:
Code:
NCT05913674
Conditions
Peritoneal Carcinomatosis
Appendiceal Neoplasms
Colorectal Cancer Metastatic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Modified early post-operative intraperitoneal chemotherapy (mEPIC)
Imaging TechniquesUltrasound and Photoacoustic Imaging of Colon and Rectal Tumor Tissue
Sponsor:
Washington University School of Medicine
Location:
Code:
NCT04339374
Conditions
Rectal Cancer
Colon Cancer
Adenomatous Polyps
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Interventions
Photoacoustic imaging, photoacoustic microscopy
Endorectal photoacoustic imaging probe
Stereotactic Boost & Short-course Radiation TherapyStereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Location:
Code:
NCT04178174
Conditions
Head and Neck Cancer
Oropharynx Cancer
Human Papilloma Virus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SABR boost and de-escalated chemoradiation
Standard chemoradiation
EMB-01EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Sponsor:
Shanghai EpimAb Biotherapeutics Co., Ltd.
Location:
Code:
NCT05176665
Conditions
Neoplasms
Neoplasm Metastasis
Metastatic Gastrointestinal Carcinoid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
EMB-01
What are clinical trials for cancer?
Clinical trials for cancer are research studies that aim to evaluate new ways to prevent, detect, or treat cancer. These trials test the safety and effectiveness of new treatments, procedures, or drugs in comparison to current standards. They may also show which medical approaches work best for certain types of cancer or groups of people.
The importance of clinical trials in cancer research
Cancer clinical trials are crucial for developing new methods to fight cancer, improving patient outcomes, and may offer participants access to cutting-edge therapies before they are widely available.
Types of cancer clinical trials
Oncology clinical trials are designed to address different aspects of cancer care, including how to treat cancer, prevent it, find it early, or improve the quality of life for people with cancer. The main types are:
Treatment trials
Treatment trials test new treatments or new combinations of treatments, such as new drugs, new surgical techniques, or new radiation therapies. The goal is to find more effective ways to treat cancer with fewer side effects.
Prevention trials
Prevention trials look for better ways to prevent cancer in people who have never had cancer or to prevent cancer from returning. These trials may include studying medicines, vaccines, vitamins, minerals, or lifestyle changes.
Screening trials
Screening trials test the best way to detect cancer, especially in its early stages. These trials study new examinations or tests that might be more effective, safer, or less invasive than the current standard screening methods.
Quality of life trials for cancer survivors
Quality of life trials (or supportive care trials) explore ways to improve comfort and the quality of life for individuals with terminal types of cancer and cancer survivors. They may study issues such as managing side effects of treatment, physical, psychological, and social side effects of cancer and its treatment.
Who can participate in oncology trials?
Eligibility for oncology trials varies widely depending on the study's objectives. Factors can include the type and stage of cancer, previous treatment history, age, gender, overall health, and other medical conditions. Researchers conducting the trial set specific criteria for each trial to ensure accurate and reliable results and to keep participants safe.
What to expect when participating in a cancer clinical trial
Participating in a cancer clinical trial often involves detailed screenings, regular health check-ups, and a structured treatment plan. Participants may receive the new treatment being tested, a standard treatment for their cancer, or a placebo, depending on the trial's design. Throughout the trial, researchers will monitor the health of participants and the effectiveness and side effects of the treatment.
Benefits and risks of participating in cancer clinical trials
Participating in cancer clinical trials offers potential benefits, including access to new treatments before they are widely available and contributing to medical research that may benefit others in the future. They also receive close monitoring from a dedicated healthcare team.
However, there are also risks, such as the new treatments under study are not always better than the standard care, and there may be unexpected side effects. Participation may also require more of their time and attention, including trips to the study site, more treatments, hospital stays, or complex dosage requirements.
Unsure about participating in clinical trials? Dive into our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
How to enroll in a clinical trial for cancer
Enrolling in a cancer clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to your cancer type. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.